GlassScriptPhysician profile
William L Jordan
NPI 1497744932
$1,683.26
in general payments reported to CMS, 2019-2025
19 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $91.22 · 2021: $445 · 2022: $432 · 2023: $54.00 · 2024: $238 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $110.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $360.33 | 2023-2025 | Gemtesa, Myfembree |
| Gilead Sciences, INC. | $222.28 | 2021-2022 | |
| Abbvie INC. | $216.32 | 2019-2022 | |
| Myovant Sciences INC. | $206.69 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $166.14 | 2019-2021 | |
| Aspira Women'S Health INC | $134.54 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $54.26 | 2019-2024 | Ajovy |
| Hologic Sales and Service, LLC | $43.18 | 2021-2022 | |
| Daiichi Sankyo INC. | $42.22 | 2019-2021 | |
| Pfizer INC. | $40.26 | 2023-2024 | |
| Covidien LP | $37.62 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.58 | 2022 | |
| Coopersurgical, INC. | $33.25 | 2022-2025 | Paragard T 380a |
| Allergan, INC. | $19.05 | 2020 | |
| Exact Sciences Corporation | $17.99 | 2025 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.76 | 2024 | |
| Qiagen, LLC | $14.61 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.83 | 2020 | |
| Glaxosmithkline, LLC. | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.